| A single arm, multicentre observational study to evaluate effectiveness of pegcetacoplan under real world conditions in patients with paroxysmal nocturnal hemoglobinuria (PNH) COMPLETE |
Ongoing |
pegcetacoplan (ASPAVELI) |
4 |
Sobi.PEGCE |
King Faisal Specialist Hospital and Research Center (Jeddah) |
| The Effect of Black Seeds (Nigella Sativa) on Prediabetic Overweight and Obese Adolescents |
Ongoing |
Nigella sativa seeds |
3 |
2230500005 |
Family and Community Medicine Center (Dammam) |
| VICTORION REAL: An international prospective Real-world study to evaluate the Effectiveness and Adherence of incLisiran plus standard of care lipid-lowering therapy compared to standard of care therapy alone in patients with primary hypercholesterolemia or mixed dyslipidemia |
Ongoing |
Inclisiran |
4 |
CKJX839A12 |
Saud Al-Babtain Cardiac Center (Dammam) , King Salman Armed Forces Hospital(Tabuk) , King Fahd Armed Forces Hospital (Jeddah) , Dr. Sulaiman Al-Habib Medical Group Rayan (Riyadh),King Faisal Specialist Hospital and Research Center (Jeddah) |
| A Randomized, Double Blinded, Comparative Observational Interventional Study to Assess The Safety And Immunogenicity Of Hepatitis B Vaccine In Newborns / Adolescents And Adults Six Months Post Vaccination |
Ongoing |
EUVAX B VACCINE |
4 |
HBV-001 |
King Fahad Medical City (Riyadh) |
| Impact of using Zinc Oxide versus Moist Exposed Wound Ointment (MEBO) in treatment of second stage pressure ulcer: A randomized control clinical trial |
Ongoing |
MEBO and Zinc oxide topical |
3 |
Version 5 |
King Abdullah Medical City (Makkah) |
| A Proof of Concept, Phase IIa, Open Label Study to Evaluate the Safety and Efficacy of Subcutaneous Implants of Afamelanotide in Patients with Xeroderma Pigmentosum (XP) |
Ongoing |
Afamelanotide |
2a |
CUV156 |
King Faisal Specialist Hospital and Research Center (Riyadh) |
| A randomized, double-blind, double-dummy, parallel-group study, comparing the efficacy and safety of remibrutinib versus teriflunomide in participants with relapsing multiple sclerosis, followed by extended treatment with open-label remibrutinib |
Ongoing |
remibrutinib |
3 |
CLOU064C123 |
King Faisal Specialist Hospital and Research Center (Jeddah) - King Abdulaziz Medical City NG (Jeddah) - King Abdulaziz Medical City NG (Riyadh) |
| An Open-label Extension Trial to Evaluate the Long-term Safety of KVD900, an Oral Plasma Kallikrein Inhibitor, for On-demand Treatment of Angioedema Attacks in Adolescent and Adult Patients with Hereditary Angioedema Type I or II |
Ongoing |
Sebetralstat |
3 |
KVD900-302 |
King Faisal Specialist Hospital and Research Center (Riyadh) |
| A Phase 3, Randomized, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Guselkumab in Participants with Fistulizing, Perianal Crohn’s Disease |
Ongoing |
Guselkumab |
3 |
CNTO1959CRD3005 |
King Faisal Specialist Hospital and Research Center (Riyadh), King Fahad Specialist Hospital (Dammam), King Saud Medical City (Riyadh), King Abdulaziz Medical City NG (Jeddah) |
| A prospective observational international study of cabozantinib tablets in combination with nivolumab as first-line treatment of advanced renal cell carcinoma in adults |
Ongoing |
Cabozantinib |
4 |
CLIN-60000 |
King Abdulaziz Medical City NG (Riyadh) |
